Aldrich Organometallic, Inorganic, Silanes, Boranes, and Deuterated Compounds

Total Page:16

File Type:pdf, Size:1020Kb

Aldrich Organometallic, Inorganic, Silanes, Boranes, and Deuterated Compounds Aldrich Organometallic, Inorganic, Silanes, Boranes, and Deuterated Compounds Library Listing – 1,523 spectra Subset of Aldrich FT-IR Library related to organometallic, inorganic, boron and deueterium compounds. The Aldrich Material-Specific FT-IR Library collection represents a wide variety of the Aldrich Handbook of Fine Chemicals' most common chemicals divided by similar functional groups. These spectra were assembled from the Aldrich Collections of FT-IR Spectra Editions I or II, and the data has been carefully examined and processed by Thermo Fisher Scientific. Aldrich Organometallic, Inorganic, Silanes, Boranes, and Deuterated Compounds Index Compound Name Index Compound Name 1066 ((R)-(+)-2,2'- 1193 (1,2- BIS(DIPHENYLPHOSPHINO)-1,1'- BIS(DIPHENYLPHOSPHINO)ETHAN BINAPH)(1,5-CYCLOOCTADIENE) E)TUNGSTEN TETRACARBONYL, 1068 ((R)-(+)-2,2'- 97% BIS(DIPHENYLPHOSPHINO)-1,1'- 1062 (1,3- BINAPHTHYL)PALLADIUM(II) CH BIS(DIPHENYLPHOSPHINO)PROPA 1067 ((S)-(-)-2,2'- NE)DICHLORONICKEL(II) BIS(DIPHENYLPHOSPHINO)-1,1'- 598 (1,3-DIOXAN-2- BINAPH)(1,5-CYCLOOCTADIENE) YLETHYNYL)TRIMETHYLSILANE, 1140 (+)-(S)-1-((R)-2- 96% (DIPHENYLPHOSPHINO)FERROCE 1063 (1,4- NYL)ETHYL METHYL ETHER, 98 BIS(DIPHENYLPHOSPHINO)BUTAN 1146 (+)-(S)-N,N-DIMETHYL-1-((R)-1',2- E)(1,5- BIS(DI- CYCLOOCTADIENE)RHODIUM(I) PHENYLPHOSPHINO)FERROCENY TET L)E 951 (1,5-CYCLOOCTADIENE)(2,4- 1142 (+)-(S)-N,N-DIMETHYL-1-((R)-2- PENTANEDIONATO)RHODIUM(I), (DIPHENYLPHOSPHINO)FERROCE 99% NYL)ETHYLAMIN 1033 (1,5- 407 (+)-3',5'-O-(1,1,3,3- CYCLOOCTADIENE)BIS(METHYLD TETRAISOPROPYL-1,3- IPHENYLPHOSPHINE)IRIDIUM(I) DISILOXANEDIYL)CYTIDINE, 97% PF6, 97% 639 (+)-B- 1050 (1,5- METHOXYDIISOPINOCAMPHEYLB CYCLOOCTADIENE)BIS(TRIPHENY ORANE LPHOSPHINE)RHODIUM(I) 1024 (+)-DI-MU-CHLOROBIS(2-(1- HEXAFLUOROPHOSP (DIMETHYLAMINO)ETHYL)PHENY 893 (1,5- L-C,N)DIPALLADIUM, CYCLOOCTADIENE)DIIODOPLATI 1139 (-)-(R)-1-((S)-2- NUM(II), 99.9% (DIPHENYLPHOSPHINO)FERROCE 889 (1,5- NYL)ETHYL METHYL ETHER, 98 CYCLOOCTADIENE)DIMETHYLPL 1145 (-)-(R)-N,N-DIMETHYL-1-((S)-1',2- ATINUM(II), 98% BIS(DIPHENYL- 244 (1- PHOSPHINO)FERROCENYL)ET BROMOVINYL)TRIMETHYLSILAN 1141 (-)-(R)-N,N-DIMETHYL-1-((S)-2- E, 97% (DIPHENYLPHOSPHINO)FERROCE 314 (1- NYL)ETHYLAMIN HYDROXYALLYL)TRIMETHYLSIL 408 (-)-3',5'-O-(1,1,3,3- ANE, 97% TETRAISOPROPYL-1,3- 378 (1-METHOXY-2- DISILOXANEDIYL)ADENOSINE, 97 (TRIMETHYLSILYL)VINYLOXY)TR 640 (-)-B- IMETHYLSILANE, 98%, MIX OF IS METHOXYDIISOPINOCAMPHEYLB 491 (1S,9S)-(-)-1,9-BIS((TERT- ORANE BUTYLDIMETHYLSILYLOXY)MET 637 (-)-DIP-CHLORIDE HYL)-5-CYANOSEMICO 1055 (1,2- 1078 (2,2'- BIS(DIPHENYLPHOSPHINO)ETHAN BIPYRIDINE)DICHLOROPALLADIU E)DICHLOROCOBALT(II) M(II) 1054 (1,2- 1079 (2,2'- BIS(DIPHENYLPHOSPHINO)ETHAN BIPYRIDINE)DICHLOROPLATINUM E)DICHLOROIRON(II), 96% (II), 98% 1056 (1,2- 579 (2- BIS(DIPHENYLPHOSPHINO)ETHAN (TRIMETHYLSILYL)ETHOXYMETH E)DICHLORONICKEL(II) YL)TRIPHENYLPHOSPHONIUM 1057 (1,2- CHLORIDE, 98% BIS(DIPHENYLPHOSPHINO)ETHAN 331 (2-BROMOETHOXY)-TERT- E)DICHLOROPALLADIUM(II), 98% BUTYLDIMETHYLSILANE, 99% 245 (2- BROMOVINYL)TRIMETHYLSILAN E, 98%, PREDOMINANTLY TRANS (c) 2007 Thermo Fisher Scientific Inc. All rights reserved. Page 1 of 26 Aldrich Organometallic, Inorganic, Silanes, Boranes, and Deuterated Compounds Index Compound Name Index Compound Name 596 (2-METHYLENE-1,3- 952 (BICYCLO(2.2.1)HEPTA-2,5- PROPANEDIYL)BIS(TRICHLOROSIL DIENE)(2,4- ANE), 98% PENTANEDIONATO)RHODIUM(I), 691 (2-METHYLPROPYL)BORONIC 97% ACID, 98% 1051 (BICYCLO(2.2.1)HEPTA-2,5- 429 (3- DIENE)(BIS(TRIPHENYLPHOSPHIN (DIETHYLAMINO)PROPYL)TRIMET E))RHODIUM(I) HE HOXYSILANE, 96% 899 (BICYCLO(2.2.1)HEPTA-2,5- 308 (3- DIENE)CHLORORHODIUM(I) (HEPTAFLUOROISOPROPOXY)PRO DIMER PYL)TRICHLOROSILANE, 97% 900 (BICYCLO(2.2.1)HEPTA-2,5- 483 (3- DIENE)DICHLOROPALLADIUM(II) (TRI(ETHOXY/METHOXY)SILYL)PR 897 (BICYCLO(2.2.1)HEPTA-2,5- OPYL)UREA, 50 WT. % SOLUTION DIENE)DICHLORORUTHENIUM(II) IN METHYL POLYMER 332 (3-BROMOPROPOXY)-TERT- 1158 (BICYCLO(2.2.1)HEPTA-2,5- BUTYLDIMETHYLSILANE, 97% DIENE)MOLYBDENUM 360 (3- TETRACARBONYL, 95% CHLOROPROPYL)TRIETHOXYSILA 273 (BROMOMETHYL)CHLORODIMET NE, 95% HYLSILANE, 97% 358 (3- 523 (CHLOROMETHYL)DIMETHYLPHE CHLOROPROPYL)TRIMETHOXYSIL NYLSILANE, 98% ANE, 97% 524 (CHLOROMETHYL)METHYLBIS(PE 413 (3- NTAFLUOROPHENYL)SILANE, 95% MERCAPTOPROPYL)TRIMETHOXY 302 (CHLOROMETHYL)TRICHLOROSIL SILANE, 95% ANE, 95% 605 (3-TRIMETHYLSILYL-2- 1117 (CUMENE)CYCLOPENTADIENYLIR PROPYNYL)TRIPHENYLPHOSPHO ON(II) HEXAFLUOROPHOSPHATE, NIUM BROMIDE 98% 548 (4-BROMOPHENOXY)-TERT- 239 (DICHLOROMETHYL)TRIMETHYLS BUTYLDIMETHYLSILANE, 97% ILANE, 97% 547 (4- 822 (DIMETHYLAMINO)TRIMETHYLTI BROMOPHENOXY)TRIMETHYLSIL N, 96% ANE, 98% 1122 (DIMETHYLAMINOMETHYL)FERR 1225 (5,6)-FULLERENE-C70 OCENE, 96% 852 (9,10-DIHYDRO-9,10- 242 (HEPTAFLUOROPROPYL)TRIMETH ANTHRACENEDIYL)TRIS(TETRAH YLSILANE, 97% YDROFURAN)MAGNESIUM 238 (IODOMETHYL)TRIMETHYLSILAN 518 (9,10-DIHYDRO-9- E, 99% ANTHRACENYL)TRIMETHYLSILA 60 (METHYL SULFIDE)-1,1,1-D3, 99.5+ NE, 99% ATOM % D 108 (ACETIC ANHYDRIDE)-D6, 99+ 61 (METHYL SULFIDE)-D6, 99.9 ATOM % D ATOM % D 1162 (ACETYLACETONATO)DICARBON 119 (METHYL SULFOXIDE)-D6, 100.0 YLRHODIUM(I), 98% ATOM % D 64 (AMMONIUM SULFATE)-D8, 98+ 186 (METHYL-D3)- ATOM % D TRIPHENYLPHOSPHONIUM 1061 (BICYCLO(2.2.1)HEPTA-2,5- BROMIDE, 99 ATOM % D DIENE)((2S,3S)- 185 (METHYL- BIS(DIPHENYLPHOSPHINO)BUTAN D3)TRIPHENYLPHOSPHONIUM E IODIDE, 99 ATOM % D 1151 (BICYCLO(2.2.1)HEPTA-2,5- 1172 (METHYLCYCLOPENTADIENYL)M DIENE)(1,1'-BIS- ANGANESE TRICARBONYL, 97% (DIPHENYLPHOSPHINO)FERROCE 411 (METHYLTHIO)TRIMETHYLSILAN N E, 95% 1064 (BICYCLO(2.2.1)HEPTA-2,5- 1060 (N3-ALLYL)((2S,3S)-(+)- DIENE)(1,4-BIS- BIS(DIPHENYLPHOSPHINO)BUTAN (DIPHENYLPHOS)BUTANE)RHODI E)PALLADIUM(II) PER UM (c) 2007 Thermo Fisher Scientific Inc. All rights reserved. Page 2 of 26 Aldrich Organometallic, Inorganic, Silanes, Boranes, and Deuterated Compounds Index Compound Name Index Compound Name 562 (PHENYLTHIOMETHYL)TRIMETHY 24 1,1,2,2-TETRACHLOROETHANE-D2, LSILANE, 99% 99.5+ ATOM % D 1123 (R)-(+)-N,N-DIMETHYL-1- 229 1,1,2,2- FERROCENYLETHYLAMINE, 97% TETRAISOPROPYLDISILANE, 97% 1091 (R,R)-(-)-N,N'-BIS(3,5-DI-TERT- 228 1,1,2,2-TETRAMETHYLDISILANE, BUTYLSALICYLIDENE)-1,2- 98% CYCLOHEXANEDIAM 391 1,1,3,3,5,5- 657 (S)-(+)-PINANEDIOL HEXAMETHYLTRISILOXANE, 95% (DICHLOROMETHYL)BORONATE, 385 1,1,3,3- 97% TETRAISOPROPYLDISILOXANE, 1124 (S)-(-)-N,N-DIMETHYL-1- 95% FERROCENYLETHYLAMINE, 95+% 384 1,1,3,3- 1092 (S,S)-(+)-N,N'-BIS(3,5-DI-TERT- TETRAMETHYLDISILOXANE, 97% BUTYLSALICYLIDENE)-1,2- 1178 1,2,3,4- CYCLOHEXANEDIAM TETRAHYDRONAPHTHALENE 589 (TERT- CHROMIUM TRICARBONYL, 98% BUTYLDIMETHYLSILYL)ACETYLE 130 1,2,3,4- NE, 99% TETRAHYDRONAPHTHALENE- 588 (TRIETHYLSILYL)ACETYLENE, D12, 98+ ATOM % D 97% 183 1,2,4,5-BENZENE-D2- 590 (TRIISOPROPYLSILYL)ACETYLEN TETRACARBOXYLIC E, 98% DIANHYDRIDE, 98 ATOM % D 445 (TRIMETHYLSILYL)ACETIC ACID, 141 1,2-BENZANTHRACENE-D12, 98 99% ATOM % D 485 (TRIMETHYLSILYL)ACETONITRIL 255 1,2- E, 99% BIS(CHLORODIMETHYLSILYL)ETH 587 (TRIMETHYLSILYL)ACETYLENE, ANE, 96% 98% 256 1,2- 310 (TRIMETHYLSILYL)METHANOL, BIS(DICHLOROMETHYLSILYL)ETH 98% ANE, 98% 1032 (TRIS(DIMETHYLPHENYLPHOSPHI 511 1,2- NE))(2,5- BIS(DIMETHYLSILYL)BENZENE, NORBORNADIENE)RHODIUM(I)PF6 98% , 97% 304 1,2- 1132 1,1''-((4,4'-BIPIPERIDINE)-1,1'- BIS(TRICHLOROSILYL)ETHANE, DIYLDICARBONYL)BIS(1'- 97% (METHOXYCARBONY 356 1,2- 1137 1,1'- BIS(TRIMETHOXYSILYL)ETHANE, BIS(DIPHENYLPHOSPHINO)FERRO 96% CENE, 97% 379 1,2- 1149 1,1'-BIS- BIS(TRIMETHYLSILYLOXY)CYCLO (CHLOROMERCURI)FERROCENE BUTENE, 95+% 1127 1,1'-DIACETYLFERROCENE, 97% 373 1,2- 1135 1,1'-DIBENZOYLFERROCENE BIS(TRIMETHYLSILYLOXY)ETHAN 1111 1,1'-DIMETHYLFERROCENE, 97% E, 98% 430 1,1'-ETHYLENEBIS(N,N,1,1- 21 1,2-DICHLOROETHANE-D4, 99 TETRAMETHYLSILANAMINE), 96% ATOM % D 1130 1,1'-FERROCENEDICARBOXYLIC 253 1,2- ACID, 96% DICHLOROTETRAMETHYLDISILA 47 1,1,1,3,3,3-HEXAFLUORO-2- NE, 98% PROPAN(OL-D), 98 ATOM % D 1113 1,2-DIFERROCENYLETHANE, 98% 436 1,1,1,3,3,3- 227 1,2-DIMETHYLDISILANE, 97% HEXAMETHYLDISILAZANE, 98% 730 1,2- 392 1,1,1,3,5,5,5- PHENYLENEBISDIMETHYLARSINE HEPTAMETHYLTRISILOXANE, 98% 737 1,2-PHENYLENEDIARSONIC ACID, 565 1,1,1-TRIPHENYLSILYLAMINE, 97% 95% 275 1,1,2,2-TETRACHLORO-1,2- 670 1,3,5,7- DIMETHYLDISILANE, 98% TETRAMETHYLPYRAZABOLE, 98% (c) 2007 Thermo Fisher Scientific Inc. All rights reserved. Page 3 of 26 Aldrich Organometallic, Inorganic, Silanes, Boranes, and Deuterated Compounds Index Compound Name Index Compound Name 154 1,3,5-TRICHLOROBENZENE-D3, 98 482 1-(3- ATOM % D (TRIMETHOXYSILYL)PROPYL)URE 489 1,3-BIS(3- A, 97% CYANOPROPYL)TETRAMETHYLDI 1148 1-(CHLOROMERCURI)FERROCENE, SILOXANE, 97% 97% 439 1,3-BIS(CHLOROMETHYL)-1,1,3,3- 191 1-(METHYL-D3)-4- TETRAMETHYLDISILAZANE, 95% PHENYLPYRIDINIUM IODIDE, 99 389 1,3- ATOM % D BIS(CHLOROMETHYL)TETRAMET 583 1-(TERT- HYLDISILOXANE, 99% BUTYLDIMETHYLSILYL)IMIDAZO 551 1,3- LE, 97% BIS(CHLOROMETHYLDIMETHYLSI 592 1-(TRIISOPROPYLSILYL)-1- LYLOXY)BENZENE, 95% PROPYNE, 98% 494 1,3- 591 1-(TRIMETHYLSILYL)-1-PROPYNE, BIS(TRIMETHYLSILYL)CARBODII 99% MIDE, 98% 564 1- 481 1,3-BIS(TRIMETHYLSILYL)UREA, (TRIMETHYLSILYL)CYCLOPROPY 95% L PHENYL SULFIDE, 98% 829 1,3-DIACETOXY-1,1,3,3- 311 1-(TRIMETHYLSILYL)ETHANOL, TETRABUTYLDISTANNOXANE, 98% 97% 582 1-(TRIMETHYLSILYL)IMIDAZOLE, 390 1,3-DICHLORO-1,1,3,3- 97% TETRAISOPROPYLDISILOXANE, 480 1- 97% (TRIMETHYLSILYLMETHYL)UREA 560 1,3- , 97% DICHLOROTETRAPHENYLDISILOX 327 1-(TRIMETHYLSILYLOXY)-1,3- ANE, 90% BUTADIENE, 98%, MIXTURE OF 388 1,3- ISOMERS DIMETHYLTETRAVINYLDISILOXA 31 1-BUTAN(OL-D), 98+ ATOM % D NE, 97% 32 1-BUTANOL-D10, 99+ ATOM % D 168 1,3-DINITROBENZENE-D4, 99 328 1- ATOM % D CYCLOHEXENYLOXYTRIMETHYL 567 1,3-DIPHENYL-1,1,3,3- SILANE,
Recommended publications
  • Inventory Size (Ml Or G) 103220 Dimethyl Sulfate 77-78-1 500 Ml
    Inventory Bottle Size Number Name CAS# (mL or g) Room # Location 103220 Dimethyl sulfate 77-78-1 500 ml 3222 A-1 Benzonitrile 100-47-0 100ml 3222 A-1 Tin(IV)chloride 1.0 M in DCM 7676-78-8 100ml 3222 A-1 103713 Acetic Anhydride 108-24-7 500ml 3222 A2 103714 Sulfuric acid, fuming 9014-95-7 500g 3222 A2 103723 Phosphorus tribromide 7789-60-8 100g 3222 A2 103724 Trifluoroacetic acid 76-05-1 100g 3222 A2 101342 Succinyl chloride 543-20-4 3222 A2 100069 Chloroacetyl chloride 79-04-9 100ml 3222 A2 10002 Chloroacetyl chloride 79-04-9 100ml 3222 A2 101134 Acetyl chloride 75-36-5 500g 3222 A2 103721 Ethyl chlorooxoacetate 4755-77-5 100g 3222 A2 100423 Titanium(IV) chloride solution 7550-45-0 100ml 3222 A2 103877 Acetic Anhydride 108-24-7 1L 3222 A3 103874 Polyphosphoric acid 8017-16-1 1kg 3222 A3 103695 Chlorosulfonic acid 7790-94-5 100g 3222 A3 103694 Chlorosulfonic acid 7790-94-5 100g 3222 A3 103880 Methanesulfonic acid 75-75-2 500ml 3222 A3 103883 Oxalyl chloride 79-37-8 100ml 3222 A3 103889 Thiodiglycolic acid 123-93-3 500g 3222 A3 103888 Tetrafluoroboric acid 50% 16872-11-0 1L 3222 A3 103886 Tetrafluoroboric acid 50% 16872-11-0 1L 3222 A3 102969 sulfuric acid 7664-93-9 500 mL 2428 A7 102970 hydrochloric acid (37%) 7647-01-0 500 mL 2428 A7 102971 hydrochloric acid (37%) 7647-01-0 500 mL 2428 A7 102973 formic acid (88%) 64-18-6 500 mL 2428 A7 102974 hydrofloric acid (49%) 7664-39-3 500 mL 2428 A7 103320 Ammonium Hydroxide conc.
    [Show full text]
  • Influence of Additives and Storage Temperature on Physicochemical and Microbiological Properties of Eye Drops Containing Cefazolin
    Acta Poloniae Pharmaceutica ñ Drug Research, Vol. 63 No. 3 pp. 225ñ234, 2006 ISSN 0001-6837 Polish Pharmaceutical Society PHARMACEUTICAL TECHNOLOGY INFLUENCE OF ADDITIVES AND STORAGE TEMPERATURE ON PHYSICOCHEMICAL AND MICROBIOLOGICAL PROPERTIES OF EYE DROPS CONTAINING CEFAZOLIN. ANNA KODYM 1, TOMASZ ZAWISZA 2, KAMILA BUèKA 2 and HELENA KUKU£A 3 1 Department of Drug Form Technology, Nicolaus Copernicus University Collegium Medicum in Bydgoszcz, 2 Department of Drug Form Technology, 3 Department of Pharmaceutical Bacteriology; K. Marcinkowski University of Medical Sciences in PoznaÒ Abstract: The purpose of the studies was to choose additives for eye drops containing cefazolin and the assess- ment of the influence of used additives and the storage temperature on the physicochemical properties and the stability of the eye drops. The drops were 1% sterile solutions of cefazolin in citrate buffer of pH 6.15-6.20. The drops were preserved with 0.002% thiomersal or 0.001% phenylmercuric borate mixed with 0.4% β- phenylethyl alcohol. Viscosity of the eye drops was increased using polyvinyl alcohol (PVAL). The pharma- ceutical compatibility test of selected additives with cefazolin showed the pharmaceutical interaction of 1% solution of cefazolin with higher than 0.003% concentration of thiomersal, 0.005% benzalkonium chloride and 0.01% chlorhexidine diacetate. The drops, protected from light, were stored at the temperature of 4∞C and 20∞C. As the criteria of the qualitative assessment of freshly prepared drops and during their storage, the following properties were considered: organoleptic analysis, sterility, pH, osmotic pressure, density, viscosity, antimicro- bial activity of cefazolin and preservation efficiency of thiomersal and phenylmercuric borate in the eye drops.
    [Show full text]
  • Safety Data Sheet Acc
    Product Distributed by Rio Grande SDS access on web: www.riogrande.com Page 1 of 13 Safety Data Sheet acc. to OSHA HCS (29 CFR 1910.1200) Printing date 03/20/2015 Reviewed on 03/20/2015 1 Identification · Product identifier · Trade name: Midas® 24K Gold Cyanide-Based Concentrate Plating Solution · Article number: 335-082 · Recommended use and restriction on use · Recommended use: Electroplating material · Restrictions on use: No further relevant information available. · Details of the supplier of the Safety Data Sheet · Manufacturer/Supplier: RIO GRANDE 7500 Bluewater Rd. NW Alburquerque NM 87121-1962 1-800-545-6566 [email protected] · Emergency telephone number: ChemTel Inc. (800)255-3924, +1 (813)248-0585 2 Hazard(s) identification · Classification of the substance or mixture GHS06 Skull and crossbones Acute Tox. 2 H300 Fatal if swallowed. Acute Tox. 2 H310 Fatal in contact with skin. Acute Tox. 3 H331 Toxic if inhaled. GHS07 Skin Sens. 1 H317 May cause an allergic skin reaction. · Additional information: There are no other hazards not otherwise classified that have been identified. 0 percent of the mixture consists of ingredient(s) of unknown toxicity. · Label elements · GHS label elements The product is classified and labeled according to the Globally Harmonized System (GHS). · Hazard pictograms GHS06 · Signal word Danger · Hazard-determining components of labeling: potassium cyanide (Contd. on page 2) 40.1.3 Page 2 of 13 Safety Data Sheet acc. to OSHA HCS (29 CFR 1910.1200) Printing date 03/20/2015 Reviewed on 03/20/2015 Trade name: Midas® 24K Gold Cyanide-Based Concentrate Plating Solution (Contd.
    [Show full text]
  • Iodomethane Safety Data Sheet 1100H01 According to Federal Register / Vol
    Iodomethane Safety Data Sheet 1100H01 according to Federal Register / Vol. 77, No. 58 / Monday, March 26, 2012 / Rules and Regulations Date of issue: 08/18/2016 Version: 1.0 SECTION 1: Identification 1.1. Identification Product form : Substance Substance name : Iodomethane CAS No : 74-88-4 Product code : 1100-H-01 Formula : CH3I Synonyms : Methyl iodide Other means of identification : MFCD00001073 1.2. Relevant identified uses of the substance or mixture and uses advised against Use of the substance/mixture : Laboratory chemicals Manufacture of substances Scientific research and development 1.3. Details of the supplier of the safety data sheet SynQuest Laboratories, Inc. P.O. Box 309 Alachua, FL 32615 - United States of America T (386) 462-0788 - F (386) 462-7097 [email protected] - www.synquestlabs.com 1.4. Emergency telephone number Emergency number : (844) 523-4086 (3E Company - Account 10069) SECTION 2: Hazard(s) identification 2.1. Classification of the substance or mixture Classification (GHS-US) Acute Tox. 3 (Oral) H301 - Toxic if swallowed Acute Tox. 3 (Dermal) H311 - Toxic in contact with skin Acute Tox. 2 (Inhalation) H330 - Fatal if inhaled Acute Tox. 3 (Inhalation:vapour) H331 - Toxic if inhaled Skin Irrit. 2 H315 - Causes skin irritation Eye Dam. 1 H318 - Causes serious eye damage Resp. Sens. 1 H334 - May cause allergy or asthma symptoms or breathing difficulties if inhaled Skin Sens. 1 H317 - May cause an allergic skin reaction Carc. 2 H351 - Suspected of causing cancer STOT SE 3 H335 - May cause respiratory irritation
    [Show full text]
  • METHYL IODIDE 1. Exposure Data
    METHYL IODIDE Data were last reviewed in IARC (1986) and the compound was classified in IARC Monographs Supplement 7 (1987). 1. Exposure Data 1.1 Chemical and physical data 1.1.1 Nomenclature Chem. Abstr. Serv. Reg. No.: 74-88-4 Chem. Abstr. Name: Iodomethane IUPAC Systematic Name: Iodomethane 1.1.2 Structural and molecular formulae and relative molecular mass H H C I H CH3I Relative molecular mass: 141.94 1.1.3 Chemical and physical properties of the pure substance (a) Description: Colourless transparent liquid, with a sweet ethereal odour (American Conference of Governmental Industrial Hygienists, 1992; Budavari, 1996) (b) Boiling-point: 42.5°C (Lide, 1997) (c) Melting-point: –66.4°C (Lide, 1997) (d) Solubility: Slightly soluble in water (14 g/L at 20°C); soluble in acetone; miscible with diethyl ether and ethanol (Budavari, 1996; Verschueren, 1996; Lide, 1997) (e) Vapour pressure: 53 kPa at 25.3°C; relative vapour density (air = 1), 4.9 (Ver- schueren, 1996) ( f ) Octanol/water partition coefficient (P): log P, 1.51 (Hansch et al., 1995) (g) Conversion factor: mg/m3 = 5.81 × ppm –1503– 1504 IARC MONOGRAPHS VOLUME 71 1.2 Production and use No information on the global production of methyl iodide was available to the Working Group. Production in the United States in 1983 was about 50 tonnes (IARC, 1986). Because of its high refractive index, methyl iodide is used in microscopy. It is also used as an embedding material for examining diatoms, in testing for pyridine, as a methy- lating agent in pharmaceutical (e.g., quaternary ammonium compounds) and chemical synthesis, as a light-sensitive etching agent for electronic circuits, and as a component in fire extinguishers (IARC, 1986; American Conference of Governmental Industrial Hygienists, 1992; Budavari, 1996).
    [Show full text]
  • The Stereochemistry of Sulfonium Salts
    University of New Hampshire University of New Hampshire Scholars' Repository Doctoral Dissertations Student Scholarship Spring 1974 THE STEREOCHEMISTRY OF SULFONIUM SALTS ROBERT L. CARET Follow this and additional works at: https://scholars.unh.edu/dissertation Recommended Citation CARET, ROBERT L., "THE STEREOCHEMISTRY OF SULFONIUM SALTS" (1974). Doctoral Dissertations. 1044. https://scholars.unh.edu/dissertation/1044 This Dissertation is brought to you for free and open access by the Student Scholarship at University of New Hampshire Scholars' Repository. It has been accepted for inclusion in Doctoral Dissertations by an authorized administrator of University of New Hampshire Scholars' Repository. For more information, please contact [email protected]. INFORMATION TO USERS This material was produced from a microfilm copy of the original document. While the most advanced technological means to photograph and reproduce this document have been used, the quality is heavily dependent upon the quality of the original submitted. The following explanation of techniques is provided to help you understand markings or patterns which may appear on this reproduction. 1. The sign or "target" for pages apparently lacking from the document photographed is "Missing Page(s)". If it was possible to obtain the missing page(s) or section, they are spliced into the film along with adjacent pages. This may have necessitated cutting thru an image and duplicating adjacent pages to insure you complete continuity. 2. When an image on the film is obliterated with a large round black mark, it is an indication that the photographer suspected that the copy may have moved during exposure and thus cause a blurred image.
    [Show full text]
  • United States Patent (19) (11) 4,161,571 Yasui Et Al
    United States Patent (19) (11) 4,161,571 Yasui et al. 45 Jul. 17, 1979 (54) PROCESS FOR PRODUCTION OF THE 4,080,493 3/1978 Yasui et al. .......................... 260/879 MALE CANHYDRDE ADDUCT OF A 4,082,817 4/1978 Imaizumi et al. ...................... 526/46 LIQUID POLYMER 4,091,198 5/1978 Smith ..................................... 526/56 75 Inventors: Seimei Yasui, Takarazuka; Takao FOREIGN PATENT DOCUMENTS Oshima, Sonehigashi, both of Japan 2262677 2/1975 France ....................................... 526/56 73) Assignee: Sumitomo Chemical Company, 44-1989 1/1969 Japan ......................................... 526/56 Limited, Osaka, Japan Primary Examiner-William F. Hamrock Attorney, Agent, or Firm-Birch, Stewart, Kolasch and 21 Appl. No.: 843,311 Birch 22 Filed: Oct. 18, 1977 57 ABSTRACT Related U.S. Application Data A process for production of the maleic anhydride ad duct of a liquid polymer having a maleic anhydride 62 Division of Ser. No. 733,914, Oct. 19, 1976, Pat, No. addition amount of 2 to 70% by weight, which com 4,080,493. prises reacting a liquid polymer having a molecular 51 Int. C.’................................................ CO8F 8/46 weight of 150 to 5,000 and a viscosity of 2 to 50,000 cp (52) U.S. C. ...................................... 526/90; 526/192; at 30 C. in the presence of at least one compound, as a 526/209; 526/213; 526/193; 526/195; 526/226; gelation inhibitor, selected from the group consisting of 526/233; 526/237; 526/238; 526/272; 525/285; imidazoles, thiazoles, metallic salts of mercapto 525/249; 525/251; 525/255; 525/245; 525/248 thiazoles, urea derivatives, naphthylamines, nitrosa (58) Field of Search ................
    [Show full text]
  • Ep 2508506 A1
    (19) & (11) EP 2 508 506 A1 (12) EUROPEAN PATENT APPLICATION (43) Date of publication: (51) Int Cl.: 10.10.2012 Bulletin 2012/41 C07C 67/343 (2006.01) C07C 227/08 (2006.01) C07F 5/02 (2006.01) C07C 229/34 (2006.01) (21) Application number: 11161611.6 (22) Date of filing: 08.04.2011 (84) Designated Contracting States: (72) Inventor: The designation of the inventor has not AL AT BE BG CH CY CZ DE DK EE ES FI FR GB yet been filed GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR (74) Representative: Kunic Tesovic, Barbara Designated Extension States: Lek Pharmaceuticals d.d. BA ME Sandoz Development Center Slovenia - Patents Verovskova 57 (71) Applicant: LEK Pharmaceuticals d.d. 1526 Ljubljana (SI) 1526 Ljubljana (SI) (54) Preparation of sitagliptin intermediates (57) The invention relates to the preparation of chiral compounds, in particular to the preparation of chiral compounds which may be used as intermediates for the preparation of anti-diabetic agents, preferably sitagliptin. EP 2 508 506 A1 Printed by Jouve, 75001 PARIS (FR) EP 2 508 506 A1 Description Field of the Intention 5 [0001] The present invention relates to the preparation of chiral compounds, in particular to the preparation of chiral compounds which may be used as intermediates for the preparation of anti-diabetic agents, preferably sitagliptin. Background prior art 10 [0002] Type II diabetes mellitus (T2DM) is a global epidemic. Therefore, the research is oriented in the development of selective inhibitors of the enzyme DPP-IV as a promising new treatment for the type II diabetes.
    [Show full text]
  • Meeting Materials)
    California State Board of Pharmacy BUSINESS, CONSUMER SERVICES AND HOUSING AGENCY 1625 N. Market Blvd, N219, Sacramento, CA 95834 DEPARTMENT OF CONSUMER AFFAIRS Phone: (916) 574-7900 GOVERNOR EDMUND G. BROWN JR. Fax: (916) 574-8618 www.pharmacy.ca.gov ENFORCEMENT AND COMPOUNDING COMMITTEE REPORT April 18, 2017 Amy Gutierrez, PharmD, Licensee Member, Chair Allen Schaad, Licensee Member, Vice Chair Greg Lippe, Public Member Stan Weisser, Licensee Member Valerie Muñoz, Public Member Ricardo Sanchez, Public Member I. Call to Order, Establishment of Quorum, and General Announcements II. Public Comments on Items Not on the Agenda/Agenda Items for Future Meetings Note: The board may not discuss or take action on any matter raised during this public comment section that is not included on this agenda, except to decide whether to place the matter on the agenda of a future meeting. [Government Code sections 11125, 11125.7(a)] III. Enforcement Matters a. University of California, San Diego’s Pilot Program to Permit Patients to Access Medications from an Automated Drug Delivery System Not Immediately Adjacent to the Pharmacy Background At the April 2015 Board Meeting, the board approved an 18-month pilot study under the auspices of the University of California, San Diego (UCSD) School of Pharmacy involving use of an automated drug delivery system (ADDS) for prescription medication from which staff of Sharp Hospital in San Diego and their families, who opted in, could pick up their outpatient medications. Consultation would be provided via telephone before medication could be dispensed to a patient for first time fills. Since that time the committee has received quarterly updates on the study, including usage of the system.
    [Show full text]
  • Bond Distances and Bond Orders in Binuclear Metal Complexes of the First Row Transition Metals Titanium Through Zinc
    Metal-Metal (MM) Bond Distances and Bond Orders in Binuclear Metal Complexes of the First Row Transition Metals Titanium Through Zinc Richard H. Duncan Lyngdoh*,a, Henry F. Schaefer III*,b and R. Bruce King*,b a Department of Chemistry, North-Eastern Hill University, Shillong 793022, India B Centre for Computational Quantum Chemistry, University of Georgia, Athens GA 30602 ABSTRACT: This survey of metal-metal (MM) bond distances in binuclear complexes of the first row 3d-block elements reviews experimental and computational research on a wide range of such systems. The metals surveyed are titanium, vanadium, chromium, manganese, iron, cobalt, nickel, copper, and zinc, representing the only comprehensive presentation of such results to date. Factors impacting MM bond lengths that are discussed here include (a) n+ the formal MM bond order, (b) size of the metal ion present in the bimetallic core (M2) , (c) the metal oxidation state, (d) effects of ligand basicity, coordination mode and number, and (e) steric effects of bulky ligands. Correlations between experimental and computational findings are examined wherever possible, often yielding good agreement for MM bond lengths. The formal bond order provides a key basis for assessing experimental and computationally derived MM bond lengths. The effects of change in the metal upon MM bond length ranges in binuclear complexes suggest trends for single, double, triple, and quadruple MM bonds which are related to the available information on metal atomic radii. It emerges that while specific factors for a limited range of complexes are found to have their expected impact in many cases, the assessment of the net effect of these factors is challenging.
    [Show full text]
  • University of California, San Diego
    UNIVERSITY OF CALIFORNIA, SAN DIEGO Structural and electronic studies of complexes relevant to the electrocatalyic reduction of carbon dioxide. A dissertation submitted in partial satisfaction of the requirements for the degree of Doctor of Philosophy in Chemistry by Eric Edward Benson Committee in charge: Professor Clifford P. Kubiak, Chair Professor Andrew G. Dickson Professor Joshua S. Figueroa Professor Arnold L. Rheingold Professor Michael J. Tauber 2012 Copyright Eric Edward Benson, 2012 All rights reserved Signature Page The dissertation of Eric Edward Benson is approved, and it is acceptable in quality and form for publication on microfilm and electronically. Chair University of California, San Diego 2012 iii DEDICATION to my family iv EPIGRAPH Epigraph The further one goes, the less one knows. –Lao Tzu v TABLE OF CONTENTS Table of Contents Signature Page ............................................................................................................. iii Epigraph ........................................................................................................................ v Table of Contents ......................................................................................................... vi List of Figures .............................................................................................................. ix Lists of Schemes .......................................................................................................... xv List of Tables .............................................................................................................
    [Show full text]
  • National Institute of Public Health and Environmental Protection Bilthoven the Netherlands
    NATIONAL INSTITUTE OF PUBLIC HEALTH AND ENVIRONMENTAL PROTECTION BILTHOVEN THE NETHERLANDS Report no. 710401027 EXPLORATORY REPORT TIN AND TIN COMPOUNDS W. Slooff, P.F.H. Bont *, J.M. Hesse and J.A. Annema August 1993 Resources Planning Consultants BV, Delft This study has been carried out at the request and for the account of the Directorate- General for Environmental Protection, Direction Substances, Safety and Radiation /i Mailing list exploratory report Tin and tin compounds 1 Directoraat-Generaal voor Milieubeheer - Directie Stoffen, Veiligheid en Straling 2 Directeur-Generaal voor Milieubeheer 3- 4 Plv. Directeur-Generaal voor Milieubeheer 5 Dr. J. de Bruijn (DGM) 6 Dr. J.A. van Zorge (DGM) 7 Dr. A.G.J. Sedee (DGM) 8 Depot Nederlandse publicaties en Nederlandse bibliografie 9 Board of Directors of the National Institute of Public Health and Environmental Protection 10 Dr.ir. G. de Mik 11 Ir. A.H.M. Bresser 12 Mrs.Drs. A.G.A.C. Knaap 13 Prof Dr. H.A.M, de Kruijf 15-18 Authors 19-22 Laboratory for Ecotoxicology 23 Project and Report Registration 24 Report Administration 25 Head of Information and Public Relations 26-28 Library RIVM 29-38 Copies RPC 39-50 Spare copies RIVM CONTENTS SUMMARY iii 1. INTRODUCTION 1 2. ACTUAL STANDARDS AND GUIDELINES 2 3. APPLICATIONS. SOURCES AND EMISSIONS 5 3.1 PRODUCTION 5 3.2 APPLICATIONS 6 3.2.1 Metallic tin 6 3.2.2 Inorganic tin compounds 8 3.2.3 Organotin compounds 8 3.3 EMISSIONS AND WASTE STREAMS 10 3.3.1 Emissions 10 3.3.2 Waste streams 13 3.4 TRENDS 14 4 OCCURRENCE AND CONCENTRATIONS .
    [Show full text]